These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7516575)

  • 1. Precision of a patient-weighted symptom score in prostatism. The DAN-PSS-1 questionnaire.
    Brasso K; Stigsby B; Pilsgård B; Nordling J
    Scand J Urol Nephrol; 1994 Mar; 28(1):71-5. PubMed ID: 7516575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does anamnestic symptom evaluation or clinical examination give enough information to evaluate the severity of obstruction in benign prostatic hyperplasia?
    Waldén M; Geirsson G; Pettersson S; Schäfer W; Dahlstrand C
    Scand J Urol Nephrol; 1995 Dec; 29(4):469-76. PubMed ID: 8719365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic outcome of transurethral prostatectomy, alpha-blockade and placebo in the treatment of benign prostatic hyperplasia. Evaluation of treatment with the Danish Prostatic Symptom Score (DAN-PSS-1) system. The ALFECH Study Group.
    Hansen BJ; Flyger H; Mortensen S; Mensink HJ; Meyhoff HH
    Scand J Urol Nephrol; 1996 Apr; 30(2):103-7. PubMed ID: 8738054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia.
    Hansen BJ; Flyger H; Brasso K; Schou J; Nordling J; Thorup Andersen J; Mortensen S; Meyhoff HH; Walter S; Hald T
    Br J Urol; 1995 Oct; 76(4):451-8. PubMed ID: 7551880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new patient weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia.
    Meyhoff HH; Hald T; Nordling J; Andersen JT; Bilde T; Walter S
    Scand J Urol Nephrol; 1993; 27(4):493-9. PubMed ID: 7512748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia.
    Netto Júnior NR; D'Ancona CA; de Lima ML
    J Urol; 1996 Jan; 155(1):200-2. PubMed ID: 7490834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study.
    Wadie BS; Ebrahim el-HE; Gomha MA
    J Urol; 2002 Jul; 168(1):132-4. PubMed ID: 12050506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Danish Prostatic Symptom Score (DAN-PSS-1) questionnaire is reliable in stroke patients.
    Tibaek S; Jensen R; Klarskov P; Iversen HK; Gard G
    Neurourol Urodyn; 2006; 25(4):319-23. PubMed ID: 16568420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatism. I. The correlation between symptoms, cystometric and urodynamic findings.
    Andersen JT; Nordling J; Walter S
    Scand J Urol Nephrol; 1979; 13(3):229-36. PubMed ID: 93780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatism symptoms in a randomly selected population: introduction of a patient administered population based symptom evaluation score.
    Hansen MV; Zdanowski A; Spångberg A
    Scand J Urol Nephrol; 1994 Dec; 28(4):371-8. PubMed ID: 7533924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Structural Equation Modeling to Demonstrate the Differential Impact of Storage and Voiding Lower Urinary Tract Symptoms on Symptom Bother and Quality of Life during Treatment for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia.
    McVary KT; Peterson A; Donatucci CF; Baygani S; Henneges C; Clouth J; Wong D; Oelke M
    J Urol; 2016 Sep; 196(3):824-30. PubMed ID: 27105760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis.
    van Venrooij GE; Boon TA
    J Urol; 1996 Jun; 155(6):2014-8. PubMed ID: 8618311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism.
    Yalla SV; Sullivan MP; Lecamwasam HS; DuBeau CE; Vickers MA; Cravalho EG
    J Urol; 1995 Mar; 153(3 Pt 1):674-9; discussion 679-80. PubMed ID: 7532231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamics and lower urinary tract symptoms.
    Michielsen DP; Wyndaele JJ
    Acta Urol Belg; 1998 Oct; 66(3):7-9. PubMed ID: 9864870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community.
    Sagnier PP; MacFarlane G; Teillac P; Botto H; Richard F; Boyle P
    J Urol; 1995 Mar; 153(3 Pt 1):669-73. PubMed ID: 7532230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of distress and symptom severity from the lower urinary tract in men: a population-based study with the DAN-PSS questionnaire.
    Engström G; Walker-Engström ML; Henningsohn L; Lööf L; Leppert J
    Fam Pract; 2004 Dec; 21(6):617-22. PubMed ID: 15465878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
    Blaivas JG
    Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. ALFECH Study Group.
    Hansen BJ; Mortensen S; Mensink HJ; Flyger H; Riehmann M; Hendolin N; Nordling J; Hald T
    Br J Urol; 1998 Jan; 81(1):36-41. PubMed ID: 9467474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.